Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes.
Phase of Trial: Phase III
Latest Information Update: 03 Mar 2017
At a glance
- Drugs Vildagliptin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Novartis
- 01 May 2012 Actual patient number is 418 according to ClinicalTrials.gov.
- 01 May 2012 Actual end date (May 2006) added as reported by ClinicalTrials.gov.
- 30 Mar 2009 New trial record